Use of ciprofloxacin in the treatment of brucellosis

  • M. Doğanay
  • B. Aygen


  1. 1.
    Khan MY, Dizon M, Kiel FW Comparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin, and other selected antimicrobial agents againstBrucella melitensis. Antimicrobial Agents and Chemotherapy 1989, 33: 1409–1410.PubMedGoogle Scholar
  2. 2.
    Bosch J, Linares J, Lopez de Goicoechea MJ, Ariza J, Cisnal MC, Martin R In vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains ofBrucella melitensis. Journal of Antimicrobial Chemotherapy 1986, 17: 459–461.PubMedGoogle Scholar
  3. 3.
    Rodriguez JAG, Sanchez JEG, Trujillano I, Bellido JLM In vitro activity of new quinolones againstBrucella melitensis. Reviews of Infectious Diseases 1989, 11, Supplement 5: 992–993.Google Scholar
  4. 4.
    Baykal M, Akalin HE, Firat M, Serin A In vitro activity and clinical efficacy of ofloxacin in infections due toBrucella melitensis. Reviews of Infectious Diseases 1989, 11, Supplement 5: 993–994.Google Scholar
  5. 5.
    Andriole VT Clinical overview of the newer 4-quinolone antibacterial agents. In: Andriole VT (ed): The quinolones. Academic Press, London, 1988, p. 155–200.Google Scholar
  6. 6.
    Salata RA, Ravdin JI Brucella species (Brucellosis). In: Mandell GL, Douglas RG, Bennet JE (ed): Principles and practice of infectious diseases. John Wiley, New York, 1985, p. 1285–1290.Google Scholar
  7. 7.
    Tilton RC, Howard BJ Antimicrobial susceptibility testing. In: Howard BJ, Klaas J, Weissfeld AS, Rubin SJ, Tilton RJ (ed): Clinical and pathogenic microbiology. CV Mosby, Washington, 1987, p. 121–156.Google Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1992

Authors and Affiliations

  • M. Doğanay
  • B. Aygen

There are no affiliations available

Personalised recommendations